Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000220010 | SCV000271680 | uncertain significance | not specified | 2016-02-15 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The p.Pro500Arg var iant in DNAAF1 has not been previously reported in individuals with pulmonary di sease, but has been identified in 0.25% (24/9432) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1388 38276). Computational prediction tools and conservation analysis suggest that th e p.Pro500Arg variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical si gnificance of the p.Pro500Arg variant is uncertain, its frequency suggests that it is more likely to be benign. |
Labcorp Genetics |
RCV000629577 | SCV000750530 | likely benign | Primary ciliary dyskinesia | 2025-01-22 | criteria provided, single submitter | clinical testing | |
UNC Molecular Genetics Laboratory, |
RCV000629577 | SCV001431625 | likely benign | Primary ciliary dyskinesia | 2018-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000629577 | SCV002702051 | benign | Primary ciliary dyskinesia | 2019-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV004725070 | SCV005334556 | uncertain significance | not provided | 2023-12-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |